4//SEC Filing
Marks Gilbert Lynn 4
Accession 0001193125-25-238984
CIK 0001880438other
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 4:01 PM ET
Size
4.6 KB
Accession
0001193125-25-238984
Insider Transaction Report
Form 4
Marks Gilbert Lynn
Director
Transactions
- Award
Common Stock
2025-10-10+10,367→ 63,749 total
Footnotes (1)
- [F1]Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001916940
Filing Metadata
- Form type
- 4
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 14, 4:01 PM ET
- Size
- 4.6 KB